MDR 1.82% 54.0¢ medadvisor limited

+1. Not bad indeed. Look at % revenue growth... demonstrates...

  1. 1 Posts.
    +1. Not bad indeed. Look at % revenue growth... demonstrates (local market) revenue generation doing well.

    • Q4 FY20 Operating Revenue (up 31.4% from Q4 FY19) & (up 40.8% from Q3 FY20)
    • Q4 FY20 Total Revenue (up 41.0% v Q4 FY19) & (up 99.8% vs Q3 FY20)
    • FY20 Operating Revenue (up 17.0% from FY19)
    • FY20 Total Revenue (up 20.8% from FY19)

    Operating Costs Q4 FY20 $1.095m improved from Q3 FY20 $2.668m from better cost management, granted yes, a significant amount of it is boosted by government grants and incentives. This is operating steadily but agree... would love to see international revenues start contributing for this to fly. $MDR reporting Asia being on track to deliver revenue next quarter is promising. Keep watching.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
54.0¢
Change
-0.010(1.82%)
Mkt cap ! $297.2M
Open High Low Value Volume
53.5¢ 54.5¢ 51.0¢ $105.8K 202.0K

Buyers (Bids)

No. Vol. Price($)
2 3780 52.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.0¢ 9069 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.